MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-14-2024
Acutus Medical DSO Ratio 2011-2026 | AFIB
Annual DSO Ratio Acutus Medical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 746 | 1.3 K | 61.2 | 93.1 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.3 K | 61.2 | 549 |
Quarterly DSO Ratio Acutus Medical
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 166 | 188 | 240 | - | 368 | 392 | 971 | - | 72.7 | 62.4 | 81.9 | - | 74.9 | 56.5 | 58.9 | - | 62.1 | 174 | 69.8 | - | 37.1 | 16.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 971 | 16.4 | 182 |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Alphatec Holdings
ATEC
|
43.1 | $ 11.77 | 0.17 % | $ 1.77 B |  USA |
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B | USA |
 |
Delcath Systems
DCTH
|
48.5 | $ 9.2 | 2.45 % | $ 330 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
49.2 | - | - | $ 3.31 B | USA |
 |
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M |  China |
 |
Aziyo Biologics
AZYO
|
59.5 | - | 1.37 % | $ 20.5 M | USA |
 |
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | USA |
 |
Second Sight Medical Products
EYES
|
49.1 | - | -0.97 % | $ 54.4 M | USA |
 |
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
60.3 | $ 9.44 | -1.05 % | $ 727 M | USA |
 |
Helius Medical Technologies
HSDT
|
53.3 | $ 2.13 | 5.97 % | $ 1.29 M | USA |
 |
InMode Ltd.
INMD
|
5.36 | $ 13.75 | 0.36 % | $ 889 M |  Israel |
 |
Cardiovascular Systems
CSII
|
61.6 | - | 0.15 % | $ 844 M | USA |
 |
Inogen
INGN
|
35.8 | $ 6.37 | 0.71 % | $ 169 M | USA |
 |
IRadimed Corporation
IRMD
|
52.7 | $ 102.03 | 1.04 % | $ 1.3 B | USA |
 |
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | USA |
 |
LivaNova PLC
LIVN
|
53.8 | $ 62.63 | 0.36 % | $ 3.42 B |  Britain |
 |
LENSAR
LNSR
|
34.4 | $ 5.56 | -0.09 % | $ 64 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | USA |
 |
AxoGen
AXGN
|
40.7 | $ 33.39 | 2.39 % | $ 1.54 B | USA |
 |
CONMED Corporation
CNMD
|
64.5 | $ 36.6 | 0.11 % | $ 1.14 B | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B | Israel |
 |
NanoVibronix
NAOV
|
29.7 | - | - | $ 1.08 M | USA |
 |
Electromed
ELMD
|
137 | $ 24.95 | 1.01 % | $ 211 M | USA |
 |
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
120 | - | - | $ 111 M |  Canada |
 |
Medtronic PLC
MDT
|
68.8 | $ 86.5 | -0.09 % | $ 111 B | USA |
 |
MiMedx Group
MDXG
|
57.3 | $ 4.16 | 0.73 % | $ 615 M | USA |
 |
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
68.6 | $ 0.67 | -3.06 % | $ 36.5 M | USA |
 |
Aethlon Medical
AEMD
|
40.7 | $ 2.34 | 8.33 % | $ 3.65 M | USA |
 |
BIOLASE
BIOL
|
42 | - | -13.19 % | $ 166 K | USA |
 |
InspireMD
NSPR
|
76 | $ 1.78 | 0.56 % | $ 114 M | Israel |
 |
Orthofix Medical
OFIX
|
60 | $ 11.78 | 0.51 % | $ 467 M |  Curacao |
 |
AdaptHealth Corp.
AHCO
|
43.8 | $ 11.59 | 0.96 % | $ 1.57 B | USA |
 |
Myomo
MYO
|
35.3 | $ 0.71 | 0.94 % | $ 29.7 M | USA |
 |
Penumbra
PEN
|
46.5 | $ 335.55 | 0.41 % | $ 13.1 B | USA |
 |
Invacare Corporation
IVC
|
206 | - | - | $ 24.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
91.8 | $ 3.75 | -4.09 % | $ 140 M |  France |
 |
Quanterix Corporation
QTRX
|
81.6 | $ 4.07 | 6.64 % | $ 174 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
74.3 | $ 16.09 | 1.13 % | $ 377 M | USA |
 |
Insulet Corporation
PODD
|
40.7 | $ 222.68 | -1.25 % | $ 15.7 B | USA |